Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Perdana Sakti Indonesia is a well-established Indonesian pharmaceutical company specializing in the manufacture and distribution of over-the-counter (OTC) and ethical medicines. The company is most recognized for its flagship product, Laxadine, which is a leading emulsion laxative in the Indonesian healthcare market. Operating with Good Manufacturing Practice (GMP) certified facilities, the company focuses on providing high-quality, affordable medicinal products to meet local healthcare needs. Its portfolio includes a variety of formulations primarily aimed at gastrointestinal health and general therapeutic areas. The company plays a significant role in the domestic pharmaceutical supply chain through its robust manufacturing and marketing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Perdana Sakti Indonesia.